Microbial Polysaccharides as Food Ingredients

Kırtel, Onur; Avşar, Gülben; Erkorkmaz, Burak Adnan; Öner, Ebru Toksoy

doi:10.1016/b978-0-12-811520-6.00012-x

Cited by 13 publications

(5 citation statements)

References 170 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is produced from the fungus Sclerotium rolfsii. In general, the term scleroglucan is used to designate similar EPSs produced from fungi such as Schizophyllum rolfsii, S. glucaniucm, S. commune, Botrytis cinerea and Epicoccum nigrum [142]. Sclerotium gum has been commercialized under the Amigel and Actigum trade names.…”

Section: Sclerotium Gummentioning

confidence: 99%

Unlocking the Potential of Fermentation in Cosmetics: A Review

Pérez-Rivero

López‐Gómez

2023

Fermentation

View full text Add to dashboard Cite

The cosmetic segment is a rapidly growing industry that has been challenged in recent years due to the origin and impact of its ingredients and manufacturing techniques. With a focus on reducing carbon dioxide emissions and improving the degradability of products, many conventional ingredients are being dismissed to meet more exigent regulations and consumer ethical demands. Biotechnology, and fermentation as the core technology, is a solution to support and drive more sustainable growth for the cosmetic industry. This review presents the latest research and development in fermentation applied to cosmetics and showcases multiple examples throughout all classes of ingredients: from functional compounds, such as oil and surfactants, to multi-faceted molecules with a wide spectrum of formulations and skin benefits derived from their emulsifying, antimicrobial or antioxidant properties. The bottlenecks associated with the commercialization of such ingredients, together with successful examples, are also discussed. The shift towards a bio-based beauty industry requires a combination of technical, regulatory and marketing efforts. Fermentation strategies to better utilize low-cost substrates and optimize microorganisms and processes will reduce overall costs, reducing the price gap with traditional methods of production. The testing, standardization and regulation of these new ingredients need to catch up with the fast research happening in the field. Finally, consumer communication is key to achieve a successful introduction of biotech ingredients in the market.

show abstract

Section: Sclerotium Gummentioning

confidence: 99%

Unlocking the Potential of Fermentation in Cosmetics: A Review

Pérez-Rivero

López‐Gómez

2023

Fermentation

View full text Add to dashboard Cite

show abstract

“…(Natalia A. Castillo, Valdez, & Fariña, 2015;Geller & Yan, 2020;Jindal & Singh Khattar, 2018;Kırtel, Avşar, Erkorkmaz, & Öner, 2017;Subhadip Mahapatra & Debdulal Banerjee, 2013a;Microbial Polymers, Applications, and Ecological Perspectives, 2021;PubChem, 2021b;J. Song et al, 2020;Valdez, Delgado, & Fariña, 2021)…”

Section: Extraction Methods Of Fungal Epssmentioning

confidence: 99%

Fungal exopolysaccharides: Properties, sources, modifications, and biomedical applications

Hamidi

Okoro

Milan

et al. 2022

Carbohydrate Polymers

View full text Add to dashboard Cite

“…In industries, it is used as gum, sweetener, flavor carrier, surface finishing additive, gelling agent, emulsifier, cryoprotector, and osmoregulator. Its bioactivity includes antitumor and antihyperlipidemic and radioprotector activities [ 84 ].…”

Section: Microbial Exopolysaccharide Composites and Their Applicationsmentioning

confidence: 99%

Microbial Exopolysaccharide Composites in Biomedicine and Healthcare: Trends and Advances

et al. 2023

View full text Add to dashboard Cite

Microbial exopolysaccharides (EPSs), e.g., xanthan, dextran, gellan, curdlan, etc., have significant applications in several industries (pharma, food, textiles, petroleum, etc.) due to their biocompatibility, nontoxicity, and functional characteristics. However, biodegradability, poor cell adhesion, mineralization, and lower enzyme activity are some other factors that might hinder commercial applications in healthcare practices. Some EPSs lack biological activities that make them prone to degradation in ex vivo, as well as in vivo environments. The blending of EPSs with other natural and synthetic polymers can improve the structural, functional, and physiological characteristics, and make the composites suitable for a diverse range of applications. In comparison to EPS, composites have more mechanical strength, porosity, and stress-bearing capacity, along with a higher cell adhesion rate, and mineralization that is required for tissue engineering. Composites have a better possibility for biomedical and healthcare applications and are used for 2D and 3D scaffold fabrication, drug carrying and delivery, wound healing, tissue regeneration, and engineering. However, the commercialization of these products still needs in-depth research, considering commercial aspects such as stability within ex vivo and in vivo environments, the presence of biological fluids and enzymes, degradation profile, and interaction within living systems. The opportunities and potential applications are diverse, but more elaborative research is needed to address the challenges. In the current article, efforts have been made to summarize the recent advancements in applications of exopolysaccharide composites with natural and synthetic components, with special consideration of pharma and healthcare applications.

show abstract

Microbial Polysaccharides as Food Ingredients

Cited by 13 publications

References 170 publications

Unlocking the Potential of Fermentation in Cosmetics: A Review

Unlocking the Potential of Fermentation in Cosmetics: A Review

Fungal exopolysaccharides: Properties, sources, modifications, and biomedical applications

Microbial Exopolysaccharide Composites in Biomedicine and Healthcare: Trends and Advances

Contact Info

Product

Resources

About